These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18981322)

  • 1. Networking between systemic angiotensin II and cardiac mineralocorticoid receptors.
    Montezano AC; Touyz RM
    Hypertension; 2008 Dec; 52(6):1016-8. PubMed ID: 18981322
    [No Abstract]   [Full Text] [Related]  

  • 2. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
    Rubattu S; Volpe M; Raman V; Lindpaintner K
    Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
    [No Abstract]   [Full Text] [Related]  

  • 3. [Left ventricular hypertrophy. Pathogenetic issues].
    Riazanov AS; Smirnova MD; Iurenev AP
    Ter Arkh; 2000; 72(2):72-7. PubMed ID: 10717936
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin in the kidney: a key to understanding hypertension?
    Steckelings UM; Rettig R; Unger T
    Cell Metab; 2007 Jan; 5(1):7-8. PubMed ID: 17189202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the cardiac renin-angiotensin system in hypertensive heart disease].
    Holmer SR; Riegger GA
    Herz; 1995 Oct; 20(5):322-9. PubMed ID: 7498879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.
    Reudelhuber TL; Bernstein KE; Delafontaine P
    Hypertension; 2007 Jun; 49(6):1196-201. PubMed ID: 17452509
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
    Vallotton MB; Braconi-Quintaje S; Lang U
    Praxis (Bern 1994); 1997 Feb; 86(7):234-7. PubMed ID: 9139339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In hypertension, the kidney rules.
    Crowley SD; Coffman TM
    Curr Hypertens Rep; 2007 Apr; 9(2):148-53. PubMed ID: 17442227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function.
    Lother A; Berger S; Gilsbach R; Rösner S; Ecke A; Barreto F; Bauersachs J; Schütz G; Hein L
    Hypertension; 2011 Apr; 57(4):746-54. PubMed ID: 21321305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt and left ventricular hypertrophy: what are the links?
    Langenfeld MR; Schmieder RE
    J Hum Hypertens; 1995 Nov; 9(11):909-16. PubMed ID: 8583471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin AT2 receptor: the younger sibling attracts attention.
    Cerbai E; Mugelli A
    Cardiovasc Res; 2004 Apr; 62(1):7-8. PubMed ID: 15023548
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
    Erne P
    Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update in the clinical management of low renin hypertension].
    Macchiavello S; Fardella C; Baudrand R
    Rev Med Chil; 2019 Apr; 147(4):490-498. PubMed ID: 31344212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and AT1 receptor in hypertrophied ventricles and aortas of sinoaortic-denervated rats.
    Miao CY; Zhang LM; Yuan WJ; Su DF
    Acta Pharmacol Sin; 2003 Aug; 24(8):812-8. PubMed ID: 12904282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac consequences of aldosterone excess in human hypertension.
    Rossi GP
    Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.